RecruitingNCT04556019

Results of Surgical Treatment of the Hepatobiliopancreatic Surgical Unit

Results of the Surgical Treatment of Patients From Hepatobiliopancreatic Surgical Unit at the Complejo Hospitalario de Navarra


Sponsor

Fundacion Miguel Servet

Enrollment

1,000 participants

Start Date

Jan 3, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The main aims of this study are: 1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit. 2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.


Eligibility

Min Age: 15 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Hepatobiliopancreatic surgery for people with bile duct diseases, liver diseases, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHepatobiliopancreatic surgery

Different surgical techniques tailored to each patient´s pathology


Locations(1)

Complejo Hospitalario de Navarra

Pamplona, Navarre, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04556019


Related Trials